Australia Top 20 Oncology Drugs Market Analysis


  • Type: Therapeutics Area
  • Published : April 2021
  • Region: APAC
  • Country: Australia
  • Report ID : 4011

  • Format: PPT, PDF

Australia Top 20 Oncology/Cancer Drugs Market: Segmented by Drug Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs, and Others), by Therapy (Chemotherapy, Targeted Therapy, and Immunotherapy), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Growth, Trends, and Forecasts (2019 – 2028)

SKU: 4011 Categories: ,

Report Overview

The Australian Top 20 oncology drugs market size stood at USD 1.1 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Oncology is a key driver for the growth of the pharmaceutical industry. One in two Australian men and women will be diagnosed with cancer by the age of 85. Cancer is a leading cause of death in Australia – almost 50,000 deaths from cancer were estimated for 2019. The market is undergoing a significant growth rate due to the factors such as the rising prevalence of different cancers, increasing new drug launches and product approvals, and growing research activities by the pharma companies in this field.

Market Growth Drivers

Cancer is a major cause of illness in Australia and has a substantial social and economic impact on individuals, families, and the community. Some of the important factors accountable for the growth of the oncology/cancer drugs market include the industry’s increased focus on cancer research, an upsurge in the aging population, and an increase in healthcare spending across the globe. Moreover, the rise in collaborations among pharmaceutical firms and Patient Assistance Programs (PAPs) offered by pharma companies (providing free or low-cost prescription drugs) is expected to fuel the oncology/cancer drugs market in the future. According to the GLOBOCAN, in 2020 nearly 200,021 new cases of cancer were diagnosed with cancer in Australia.

Cancer research and therapeutic development programs that involve various approaches to address cancer, different sets of IPs (intellectual property), and encouraging effects seen so far justify this sector as one of the most fascinating ones in the Australian life science industry.


The below pie chart describes the proposition of a divided total number of cases under major cancer types in the Australian market.

The below bar graph represents the Age-standardized incidence and mortality rates for the top 10 cancer in Australia.


1. Australian Oncology Drug Management Market Overview…….…………………….
A. Market Size
2. Market Growth Drivers……………………………………………………………………….
A. Rise in incidence of cancer across the globe
B. Increasing Geriatric Population
C. Increase in government expenditures on healthcare
3. Epidemiology………….……….…………….……………..…….……………………………
A. Prevalence number of new cases in 2020
B. Age-standardized incident and mortality rate
4. Oncology Drugs Market Segmentation….…………………………….………….………
A. Drug Class
I. Antibody-Drug Conjugates
II. Small-Molecule Drugs
III. Monoclonal Antibodies
IV. Others
B. Therapy
I. Chemotherapy
II. Molecular Targeted Therapy
III. Radiation Therapy
IV. Immunotherapy
C. Distribution channel
I. Hospital Pharmacies
II. Retail Pharmacies
5. Oncology Major Drugs Major Products……………….…………….……………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………….……………………………………….
A. Major Players
B. Competitive Situations and Trends
7. Key Company Profiles………….……………………………………….…………………
A. Kazia Therapeutics Biotech company overview, Product & Services, Strategies & Financials
B. Prescient Therapeutics biotech company overview, Product & Services, Strategies & Financials
C. Invion Limited biotech company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………….…….……….…
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………………
A. New Trends and Development of Oncology Drugs Market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Class:

Based on the drug class which is used for the treatment of cancer are Antibody-Drug Conjugates (ADCs): they home in on a specific target expressed by cancer cells, and once the target is reached, a cytotoxic agent is released and delivered to induce cell death, Monoclonal antibodies (mAbs): that are developed in a laboratory and designed specifically to recognize and bind to targets on the outside of cancer cells or in the circulation, Small-molecule drugs: gents that are small enough to easily enter their target cells to induce their effects and others.

By Therapy:

Based on the therapy, molecular targeted therapy segment was the leading class of cancer treatment in the Top 20 in Australia with sales of $320m in 2008, which was driven by the increased uptake of high-priced products and a lack of generic competition. The immunotherapy segment, on the other hand, is anticipated to expand with the highest growth rate during the forecast period. The highest growth rate of the segment is due to the launch of various drugs of this type by the key industry players and extensive research and development by the research organizations.

By Distribution Channel:

In terms of distribution channels, the market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment is projected to have dominant during the forecast period. The increasing prescription of medications at hospitals due to more frequent diagnoses at these institutions is the reason for the dominance of this segment.

Moreover, the online pharmacy segment is likely to expand with the highest CAGR owing to its rising popularity due to its ease and convenience.

Major Players

Australian biotech companies are heavily involved in trying to address some of the biggest unmet medical needs in the world – with the various forms of cancer being at the forefront of research and drug development, and the key biotech players contributing towards the major growth of the oncology market are PaImugene (IMU:ASX), Kazia Therapeutics (KZA:ASX), Amplia Therapeutics (ATX:ASX), Pharmaxis (PXS:ASX), Dimerix (DXB:ASX), Exopharm (EX1:ASX), Prescient Therapeutics (PTX: ASX), and others.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements